Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. scores highest on Torque (51) and lowest on Price (0). Its PosiPenta is 24.91 out of 100, weaker than most similar companies.
On the Penta Grid this week, Obsidian Therapeutics, Inc. is Grid #811 of 837 in the Healthcare sector in United States, and Grid #3,819 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Obsidian Therapeutics, Inc. | 24.91 | 0 | 26 | 16 | 51 | 32 |
| Kura Oncology, Inc. | 35.23 | 4 | 32 | 61 | 25 | 54 |
| Alumis Inc. | 31.51 | 31 | 29 | 26 | 42 | 30 |
| P3 Health Partners Inc. | 31.02 | 6 | 41 | 34 | 17 | 57 |
| Corvus Pharmaceuticals, Inc. | 40.68 | 18 | 34 | 37 | 69 | 45 |
| Ardelyx, Inc. | 40.67 | 13 | 81 | 22 | 33 | 55 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.22 |
| P/B ratio | -2.63 |
EEarnings
| Trailing EPS | ₹-154.39 |
| Forward EPS | ₹-201.74 |
NNitro
| Price | 1114.80 |
| 52-week high | 4732.91 |
| 52-week low | 1101.53 |
| Fall from 52-week high | 76.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.10 |
AAnchor
| Beta (price swings) | 2.64 |
| Market cap | ₹6,886 Cr |
| Insider holding | 0.81% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Obsidian Therapeutics, Inc.'s PosiPenta score?
Obsidian Therapeutics, Inc.'s PosiPenta is 24.91 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Obsidian Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Obsidian Therapeutics, Inc. is Grid #811 of 837 in the Healthcare sector in United States, and Grid #3,819 of 4,000 in United States.
Which PosiPenta pillar is strongest for Obsidian Therapeutics, Inc.?
Torque (durability), with a score of 51 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Obsidian Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.